Jane Street Group, LLC Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$110.08 - $142.92 $3.17 Million - $4.12 Million	28,800 Added 126.87%	51,500 $6.11 Million
Q4 2021 Feb 15, 2022	BUY	$99.73 - $148.48 $1.84 Million - $2.73 Million	18,400 Added 427.91%	22,700 $3.13 Million
Q3 2021 Nov 16, 2021	SELL	$98.85 - $138.91 $7.94 Million - $11.2 Million	-80,300 Reduced 94.92%	4,300 $597,000
Q4 2020 Feb 17, 2021	BUY	$65.07 - $98.24 $5.23 Million - $7.9 Million	80,400 Added 1914.29%	84,600 $7.25 Million
Q3 2020 Nov 17, 2020	SELL	$59.04 - $77.95 $572,688 - $756,115	-9,700 Reduced 69.78%	4,200 $273,000
Q2 2020 Aug 17, 2020	BUY	$29.01 - $74.23 $269,793 - $690,339	9,300 Added 202.17%	13,900 $1.02 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $187,956 - $265,190	4,600 New	4,600 $250,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.